FDA Black Box Warnings

The FDA uses a few different types of warnings to let consumers know about the hazards of a particular product. When a product is dangerous enough to seriously threaten the health of its users, the FDA may issue its toughest warning, known as a black box warning. The black box warning, named after the thick black outline on the FDA warning document, marks the most dangerous products allowed on the market.

The FDA creates several necessary steps for products given this label. The most obvious is the attachment of an additional warning label in product literature or packaging. This label discusses in general terms that the product may be useful, but should not necessarily be considered safe. All medications included in the black box warning program, such as the heartburn medication Reglan, contain these explicit warnings.

Each drug manufacturer responsible for making a drug carrying this label must then fulfill additional requirements for the FDA. These extra requirements are part of what is known as a risk mitigation strategy. For many drugs, these additional precautions include publishing extra warnings inside packaging and with pieces of literature on the medication.

One of the major problems with a black box warning is that it does not necessarily prompt conversation over the risks involved with the drug. If you or someone you love has developed a neuromuscular disorder because of Reglan, there may be legal action available. To discuss the details of your case with an experienced advisor, contact the Reglan lawyers of Williams Kherkher today at 800-761-3187.